Aphria Reports Independent Proxy Firms Approve Of Tilray Merger

Aphria Inc (TSX: APHA) (NASDAQ: APHA) is evidently looking to drum up shareholder support for its proposed transaction with Tilray Inc (NASDAQ: TLRY). The firm this morning released that two separate proxy advisory firms have provided favourable voting recommendations to institutional investors for the transaction.

The two firms, Institutional Shareholder Services, and Glass Lewis and CO, have reportedly recommended that shareholders voting in favour of the transaction. In reaching its conclusion, ISS reportedly highlighted US$78 million in pre-tax cost synergies within two years of the transaction closing as well as the pro-forma revenue figures as being a large part of its positive recommendation. Also highlighted was the pro-forma European operations that include both cultivation and distribution across the EU.

Glass Lewis meanwhile was much less specific in its conclusion, instead referencing that the transaction implies “a standard market premium,” for both entities within the transaction.

Shareholders are set to vote on the transaction on April 14 at a special meeting.

Aphria Inc last traded at $22.75 on the TSX.


Information for this briefing was found via Sedar and Aphria Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

PMET Resources: Lithium Feasibility Study Sees Economics Tumble

Gold Is Not Rising. Confidence Is Collapsing | Todd “Bubba” Horwitz

IAMGOLD: The Quebec Buying Spree

Recommended

PTX Metals Compiles Geophysical Data For W2 Project Following Magnetic Survey

Altamira Gold Sees Aura Minerals Increase Stake To 18.2%

Related News

Hexo Shareholders Approve Tilray Buyout, Company Loses $117 Million In Fiscal Q3

Hexo Corp (TSX: HEXO) shareholders have formally approved the proposed acquisition by Tilray Brands (TSX:...

Thursday, June 15, 2023, 08:45:41 AM

Tilray Selected To Supply Medical Cannabis For French Experimental Program

Tilray Inc (NASDAQ: TLRY) has expanded its international operations to now include France. The company...

Tuesday, January 26, 2021, 07:55:19 AM

Cantor Releases Industry Report For Cannabis, Aphria Remains Top Pick

Recently, Cantor Fitzgerald released their monthly review of Hifyre data for the four weeks ending...

Sunday, October 4, 2020, 01:57:00 PM

Tilray to Enter Cannabis Retail Space

Tilray Inc (NASDAQ: TLRY) announced this morning that it will be entering the cannabis retail...

Thursday, August 29, 2019, 09:55:25 AM

Tilray: Canaccord Lowers Target On Expected Adult-Use Sales Slump, Revised Hexo Deal

Earlier this week, Tilray Brands (TSX: TLRY) announced an update to their strategic alliance with...

Friday, June 17, 2022, 10:49:29 AM